» Articles » PMID: 22228542

Induction and Repair of DNA Double-strand Breaks Assessed by Gamma-H2AX Foci After Irradiation with Pulsed or Continuous Proton Beams

Overview
Date 2012 Jan 10
PMID 22228542
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In particle tumor therapy including beam scanning at accelerators, the dose per voxel is delivered within about 100 ms. In contrast, the new technology of laser plasma acceleration will produce ultimately shorter particle packages that deliver the dose within a nanosecond. Here, possible differences for relative biological effectiveness in creating DNA double-strand breaks in pulsed or continuous irradiation mode are studied. HeLa cells were irradiated with 1 or 5 Gy of 20-MeV protons at the Munich tandem accelerator, either at continuous mode (100 ms), or applying a single pulse of 1-ns duration. Cells were fixed 1 h after 1-Gy irradiation and 24 h after 5-Gy irradiation, respectively. A dose-effect curve based on five doses of X-rays was taken as reference. The total number of phosphorylated histone H2AX (gamma-H2AX) foci per cell was determined using a custom-made software macro for gamma-H2AX foci counting. For 1 h after 1-Gy 20-MeV proton exposures, values for the relative biological effectiveness (RBE) of 0.97 ± 0.19 for pulsed and 1.13 ± 0.21 for continuous irradiations were obtained in the first experiment 1.13 ± 0.09 and 1.16 ± 0.09 in the second experiment. After 5 Gy and 24 h, RBE values of 0.99 ± 0.29 and 0.91 ± 0.23 were calculated, respectively. Based on the gamma-H2AX foci numbers obtained, no significant differences in RBE between pulsed and continuous proton irradiation in HeLa cells were detected. These results are well in line with our data on micronucleus induction in HeLa cells.

Citing Articles

Emergence of FLASH‑radiotherapy across the last 50 years (Review).

Li M, Zhou S, Dong G, Wang C Oncol Lett. 2024; 28(6):602.

PMID: 39493433 PMC: 11529378. DOI: 10.3892/ol.2024.14735.


The current status of FLASH particle therapy: a systematic review.

Atkinson J, Bezak E, Le H, Kempson I Phys Eng Sci Med. 2023; 46(2):529-560.

PMID: 37160539 PMC: 10209266. DOI: 10.1007/s13246-023-01266-z.


Biosensor for deconvolution of individual cell fate in response to ion beam irradiation.

Niklas M, Schlegel J, Liew H, Zimmermann F, Rein K, Walsh D Cell Rep Methods. 2022; 2(2):100169.

PMID: 35474967 PMC: 9017136. DOI: 10.1016/j.crmeth.2022.100169.


Models for Translational Proton Radiobiology-From Bench to Bedside and Back.

Suckert T, Nexhipi S, Dietrich A, Koch R, Kunz-Schughart L, Bahn E Cancers (Basel). 2021; 13(16).

PMID: 34439370 PMC: 8395028. DOI: 10.3390/cancers13164216.


The Importance and Clinical Implications of FLASH Ultra-High Dose-Rate Studies for Proton and Heavy Ion Radiotherapy.

Colangelo N, Azzam E Radiat Res. 2019; 193(1):1-4.

PMID: 31657670 PMC: 6949397. DOI: 10.1667/RR15537.1.


References
1.
Kobayashi J, Iwabuchi K, Miyagawa K, Sonoda E, Suzuki K, Takata M . Current topics in DNA double-strand break repair. J Radiat Res. 2008; 49(2):93-103. DOI: 10.1269/jrr.07130. View

2.
Cai Z, Vallis K, Reilly R . Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software. Int J Radiat Biol. 2009; 85(3):262-71. DOI: 10.1080/09553000902748757. View

3.
Wyman C, Kanaar R . DNA double-strand break repair: all's well that ends well. Annu Rev Genet. 2006; 40:363-83. DOI: 10.1146/annurev.genet.40.110405.090451. View

4.
Roig A, Hight S, Shay J . Two- and three-dimensional models for risk assessment of radiation-enhanced colorectal tumorigenesis. Radiat Res. 2009; 171(1):33-40. PMC: 2659457. DOI: 10.1667/RR1415.1. View

5.
MacPhail S, Banath J, Yu T, Chu E, Lambur H, Olive P . Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol. 2003; 79(5):351-8. DOI: 10.1080/0955300032000093128. View